Previous close | 22.20 |
Open | 22.18 |
Bid | 22.55 x 200 |
Ask | 22.67 x 100 |
Day's range | 22.09 - 22.72 |
52-week range | 8.92 - 26.73 |
Volume | |
Avg. volume | 327,557 |
Market cap | 1.043B |
Beta (5Y monthly) | 1.87 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.44 |
Earnings date | 07 Nov 2024 - 11 Nov 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 28.90 |
Despite a slight revenue dip, BioLife Solutions Inc (BLFS) showcases strong cell processing growth and improved margins, setting a positive outlook for the year.
BioLife Solutions (BLFS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Here is how Eli Lilly (LLY) and BioLife Solutions, Inc. (BLFS) have performed compared to their sector so far this year.